PYC Therapeutics

PYC Therapeutics is a drug development company that provides next-generation RNA therapies to address unmet disease needs. PYC Therapeutics possesses world-leading RNA-targeted therapeutic design capabilities, supported by our revolutionary delivery technology based on cell-penetrating peptides (CPP), to overcome the "delivery challenge" in genomic therapies. With differentiated drug delivery capabilities and a team of RNA drug design experts, PYC Therapeutics has the skills and means to discover and develop RNA-targeted therapies in a truly innovative way. The company has three well-defined preclinical programs targeting inherited retinal diseases and places a particular focus on central nervous system disorders.